Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes

Arthritis and Rheumatism

Volumn 46, Issue 11, 2002, Pages 2867-2877

  Sen, Malini ^a,c   Reifert, Jack ^a   Lauterbach, Kevin ^a   Wolf, Vladimir ^b   Rubin, Jeffrey S ^b   Corr, Maripat ^a   Carson, Dennis A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; FIBRONECTIN; FRIZZLED RECEPTOR PROTEIN 1; LYMPHOID ENHANCER FACTOR 1; MATRIX PROTEIN; METALLOPROTEINASE; PROTEIN ANTIBODY; RECEPTOR PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT SFRP1; SCLEROPROTEIN; STROMELYSIN; T CELL FACTOR 4; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 ANTIBODY;

ARTICLE; BONE REMODELING; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; JOINT FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; METALLOENDOPEPTIDASES; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANSFECTION; UP-REGULATION;

EID: 0036845163     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10593     Document Type: Article

References (49)

1. Albani S, Carson DA. Etiology and pathogenesis of rheumatoid arthritis. In: Koopman WJ, editor. Arthritis and Allied Conditions. 13th Ed. New York: Williams & Wilkins; 1997. p. 979-89.
2. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
3. Lindhout E, Eijk M, Pel M, Lindemann J, Dinant HJ, Groot C. Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol 1999;162:5949-56.
4. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A 2000;97:2791-6.
5. Sen M, Chamorro M, Reifert J, Corr M, Carson DA. Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 2001;44:772-81.
6. Harada S, Yamamura M, Okamoto H, Morita Y, Kawashima M, Aita T, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1508-16.
7. Peichl P, Pursch E, Broll H, Lindley IJ. Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: Polyclonal activation in chronic synovial tissue inflammation. Rheumatol Int 1999;18:141-5.
8. Badolato R, Oppenheim JJ. Role of cytokines, acute phase proteins and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996;26:526-38.
9. Monier S, Reme T, Cognot C, Gao QL. Growth factor activity of IL-6 in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:595-602.
10. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999;26:717-9.
11. Pap T, Müller-Ladner U, Gay RE, Gay S. Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000;2:361-7.
12. Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
13. Tetlow LC, Lees M, Ogata Y, Nagase H, Woolley DE. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 1993;13:53-9.
14. Wodarz A, Nusse R. Mechanisms of wnt signaling in development. Annu Rev Cell Dev Biol 1998;14:59-88.
15. Cadigan KM, Nusse R. Wnt signaling: A common theme in animal development. Genes Dev 1997;11:3286-305.
16. Moon RT, Brown JD, Torres M. Wnts modulate cell fate and behavior during vertebrate development. Trends Genet 1997;13:157-60.
17. Hartmann C, Tabin CJ. Dual roles of wnt signaling during chondrogenesis in the chick limb. Development 2000;127:3141-59.
18. Hartmann C, Tabin CJ. Wntl4 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 2001;104:341-51.
19. Barnes MR, Duckworth DM, Beeley LJ. Frizzled proteins constitute a novel family of G protein-coupled receptors, most closely related to the secretin family. Trends Pharmacol Sci 1998;19:399-400.
20. He X, Saint-Jeannet J-P, Wang Y, Nathans J, Dawid I, Varmus H. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 1997;275:1652-4.
21. Giarre M, Samenov MV, Brown AMC. Wnt signaling stabilizes the dual function protein beta-catenin in diverse cell types. Ann N Y Acad Sci 1998;857:43-55.
22. Wong GT, Gavin BJ, McMahon AP. Differential transformation of mammary epithelial cells by wnt genes. Mol Cell Biol 1994;14:6278-86.
23. Olson DJ, Papkoff J. Regulated expression of Wnt family members during proliferation of C57mg mammary cells. Cell Growth Differ 1994;5:197-206.
24. 2+ pathways. Oncogene 1999;18:7860-72.
25. Sheldahl LC, Park M, Malbon CC, Brown JD, Moon RT. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein dependent manner. Curr Biol 1999;9:695-8.
26. 2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet 2000;16:279-83.
27. Bafico A, Gazit A, Wu-Morgan SS, Yaniv A, Aaronson SA. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene 1998;16:2819-25.
28. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, et al. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J Cell Biol 2001;152:87-96.
29. Gradl D, Kuhl M, Wedlich D. The Wnt/Wingless signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol 1999;19:5576-87.
30. Cavallo R, Rubinstein D, Peifer M. Armadillo and dTCF: A marriage made in the nucleus. Curr Opin Genet Dev 1997;7:459-66.
31. Kuhl M, Wedlich D. Wnt signaling goes nuclear. Bioessays 1997;19:101-4.
32. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A 1997;94:6770-5.
33. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, et al. Secreted Frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 2000;275:4374-82.
34. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between IFN-γ and TNF-α on HLA-DR expression, proliferation, collagenase production, and GM-CSF production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-8.
35. Vartio T, Vaheri A, Von Essen R, Isomaki H, Stenman S. Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest 1981;11:207-12.
36. Carsons S, Lavietes BB, Diamond HS, Kinney SG. The immunoreactivity, ligand, and cell binding characteristics of rheumatoid synovial fluid fibronectin. Arthritis Rheum 1985;28:601-12.
37. Pukrop T, Gradl D, Henningfeld KA, Knochel W, Wedlich D, Kuhl M. Identification of two regulatory elements within the high mobility group box transcription factor XTCF-4. J Biol Chem 2001;276:8968-78.
38. Hedgepeth CM, Conrad LJ, Zhang J, Huang H-C, Lee VMY, Klein PS. Activation of the wnt signaling pathway: A molecular mechanism for lithium action. Dev Biol 1997;185:82-91.
39. Kirstein M, Sanz L, Quinones S, Moscat J, Diaz-Meco MT, Saus J. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J Biol Chem 1996;271:18231-6.
40. Cheung NT, Dawes PT, Poulton KV, Ollier WER, Taylor DJ, Mattey DL. High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis. J Rheumatol 2000;27:882-7.
41. Novak A, Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 1999;56:523-37.
42. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis. Science 2000;287:1606-9.
43. Gharaee-Kermani M, Wiggins R, Wolber F, Goyal M, Phan SH. Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol 1996;148:961-7.
44. Jeong J, Han I, Lim Y, Kim J, Park I, Woods A, et al. Rat embryo fibroblasts require both the cell-binding and the heparin-binding domains of fibronectin for survival. Biochem J 2001;356:531-7.
45. Towle CA, Wright M, Hecht AC, Kuong SJ, Papanicolas LE, Totkovic R, et al. A matrix metalloproteinase proenzyme activator produced by articular cartilage. Biochem Biophys Res Commun 1998;247:324-31.
46. Rudnicki JA, Brown AMC. Inhibition of chondrogenesis by wnt gene expression in vivo and in vitro. Dev Biol 1997;185:104-18.
47. Hall BK, Miyake T. Divide, accumulate, differentiate: Cell condensation in skeletal development revisited. Int J Dev Biol 1995;39:881-93.
48. Brama PAJ, TeKoppele J M, Beekman B, van El B, Barneveld A, van Weeren PR. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid. Ann Rheum Dis 2000;59:155-7.
49. Bord S, Horner A, Hembry RM, Compston JE. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Roles in skeletal development. Bone 1998;23:7-12.